Targeted Designs for Clinical Trials

Venue: The Downtown Club

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: Jul 19, 2007 End Date/Time: Jul 20, 2007
Abstract Submission Date: Jul 08, 2007
Report as Spam

Description

Abstract Deadline: June 19, 2007


Click here to submit an abstract
Click here for a Printer Friendly Brochure


Learn from industry leading experts as they discuss strategies to accelerate drug development, lower trial costs and reduce development risks.  Join GTCbio for an in-depth look at designing clinical trials from Early Stage Trials and into Phase IV & Post-Marketing Studies. 



Allen D. Roses, Senior Vice President of Pharmacogenetics for GlaxoSmithKline delivers the keynote address on “New Opportunities to Bring Drugs and Pharmacogenetics into the Clinic”. 

 


Discussions Include:




  • Using Proof of Concept (PoC) Trials to spot dead-ends in drug development



  • Improving the rate of success at Phase III using adaptive clinical trials


  • Accelerating drug development by using combination Phase II/III trials

  • Early stopping rules for clinical trials

  • Using PK/PD modeling in rational drug development

  • Overcoming challenges to bringing predictive test results into the clinic

  • The role of biomarkers in drug development


  • Imaging in targeted clinical trial designs

  • Rationale and Approaches for Phase IV Studies   



 


 



Case Studies Include





Tools to Define the Relevance of PK/PD Parameters to the Efficacy, Toxicity and Emergence of Resistance of Antimicrobials 
Merck Research Laboratories 

Human Doses and Recommendations for Clinical Trial Design through Case Studies 
Wyeth Research    


Roche Diagnostics’ AmpliChip Cytochrome P450 Genotyping Test 
Roche Diagnostics 



 





Additional Presentations From:


AstraZeneca Pharmaceuticals


Aureon Biosciences 


BioImaging Technologies


GlaxoSmithKline 


H.


Lee


Moffitt

Cancer

Center 


Iris Global Clinical Trial Solutions 


Johnson & Johnson 


Kendle International 



Merck Research Laboratories 


PDL BioPharma 


Pfizer 


St. Jude Children’s


Research

Hospital 



Tessella 


Vanderbilt

University 


Virginia

Commonwealth

University   



Windber Research Institute 


Wolf, Greenfield & Sacks 


And more!  


Join us on July 19-20, 2007 at The Downtown Club in Philadelphia’s Historic Public Ledger Building for GTCbio`s "Targeted Designs for Clinical Trials" conference.   


Attend with your colleagues:  Register 2, the 3rd goes free!



 


Venue